MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

This cohort has 196,966 works, more than the 100,000-row export cap: the file will contain the first 100,000 ordered by OpenAlex id, and says so in its last line. Narrow the cohort, page the API, or rebuild the frame from the repository for the rest. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

196,966 results · 2 filters active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
196,966 works in the cohort · of 4,299,418page 279 of 3,940

Labels cover 472 of 196,966 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 196,966 of 196,966 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

fundno affunlabeled
Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal–bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN<sup>®</sup> Basal–Bolus Type 1): 2‐year results of a randomized clinical trial
Bruce W. Bode, John B. Buse, Miles Fisher, Satish K. Garg, Michel Marre, Ludwig Merker +5 more
2013· article· en· Diabetic Medicine· Medicine
machine prediction:candidate · noneconsensus · none
95
citations
fundvenueno affunlabeled
Nonpharmacological Treatment of Alzheimer Disease
Clive Ballard, Zunera Khan, Hannah Clack, Anne Corbett
2011· review· en· The Canadian Journal of Psychiatry· Medicine
machine prediction:candidate · noneconsensus · none
95
citations
fundno affunlabeled
The Early Years: Child Well-being and the Role of Public Policy
Martín Ardanaz, Edna Armendáriz, Jere R. Behrman, Samuel Berlinski, Julián Cristia, Luca Flabbi +5 more
2015· book· en· Inter-American Development Bank eBooks· Health Professions
machine prediction:candidate · noneconsensus · none
95
citations
fundno affunlabeled
<i>Genetic Factors in Autoimmune Myasthenia Gravis</i>
Matthieu Giraud, Claire Vandiedonck, Henri‐Jean Garchon
2008· article· en· Annals of the New York Academy of Sciences· Medicine
machine prediction:candidate · noneconsensus · none
95
citations

How this was built: Screen · Findings · About